Literature DB >> 31620651

Gastroesophageal reflux in cystic fibrosis across the age spectrum.

Frederick W Woodley1,2, Don Hayes2,3, Benjamin T Kopp2,3, Melissa Moore-Clingenpeel4, Rodrigo Strehl Machado5, Christopher J Nemastil3, Sudarshan Jadcherla2,6, Carlo Di Lorenzo1,2, Ajay Kaul7,8, Hayat Mousa9,10.   

Abstract

BACKGROUND: Scientific advances have improved longevity in cystic fibrosis (CF) patients and many of these patients can expect to experience age-related gastrointestinal co-morbidities. We aimed to assess the extent to which age might impact gastroesophageal reflux (GER) in patients with CF.
METHODS: Our esophageal pH-multichannel intraluminal impedance monitoring database was searched for tracings belonging to CF patients ≥2 years old without prior fundoplication and not taking anti-reflux medications immediately prior (within 7 days) and during the study. Tracings were retrospectively analyzed; Impedance and pH variables were evaluated with respect to age and pulmonary function.
RESULTS: Twenty-eight patients were enrolled; 16 children (3.1-17.7 years) and 12 adults (18.2-48.9 years). Among pH probe parameters, correlation analysis showed DeMeester score (P=0.011) and number of acid reflux events lasting >5 minutes (P=0.047) to be significantly correlated with age. Age was not significantly correlated with any of the impedance parameters. Age was negatively correlated with baseline impedance (BI) in the distal esophagus (r=-0.424, P=0.023) and BI was negatively correlated with several pH parameters, including reflux index (r=-0.553, P=0.002), number of total acid reflux events (r=-0.576, P=0.001), number of acid reflux events lasting >5 minutes (r=-0.534, P=0.003), and DeMeester score (r=-0.510, P=0.006). Pulmonary function (percent predicted forced expiratory volume in one minute; ppFEV1) was negatively correlated with age (r=-0.494, P=0.0007). The interaction of age and ppFEV1 and any of the reflux parameters, however, was not significant (P>0.05); the strongest evidence for an interaction was found for the number of acid reflux events reaching the proximal esophagus, but this interaction still did not reach statistical significance (P=0.070).
CONCLUSIONS: In a small cohort, we found evidence that age may be associated with increased acid exposure and that both age and increased acid exposure are associated with reduced BI in the distal esophagus. The negative relationship between pulmonary function and age in our cohort is not related to GER. This pilot study supports the need for esophageal assessment and treatment of GER as standard components of clinical care for an aging CF population. 2019 Translational Gastroenterology and Hepatology. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis (CF); age; esophageal pH monitoring and multichannel intraluminal impedance (EPM-MII); gastroesophageal reflux (GER); pH-impedance monitoring

Year:  2019        PMID: 31620651      PMCID: PMC6789305          DOI: 10.21037/tgh.2019.08.11

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN: 2415-1289


  43 in total

1.  The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis.

Authors:  Kara Palm; Gregory Sawicki; Rachel Rosen
Journal:  Pediatr Pulmonol       Date:  2011-12-07

2.  Chemical clearance in infants and children with Acid reflux in the physiologic range.

Authors:  Frederick W Woodley; Rodrigo Machado; Carlo Di Lorenzo; Hayat Mousa
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-06       Impact factor: 2.839

3.  Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.

Authors:  Renato Caviglia; Mentore Ribolsi; Nicola Maggiano; Armando M Gabbrielli; Sara Emerenziani; Michele Pier Luca Guarino; Simone Carotti; Fortunéé Irene Habib; Carla Rabitti; Michele Cicala
Journal:  Am J Gastroenterol       Date:  2005-03       Impact factor: 10.864

Review 4.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

5.  Dilated intercellular spaces: a morphological feature of acid reflux--damaged human esophageal epithelium.

Authors:  N A Tobey; J L Carson; R A Alkiek; R C Orlando
Journal:  Gastroenterology       Date:  1996-11       Impact factor: 22.682

Review 6.  The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis.

Authors:  William J Barlow; Roy C Orlando
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

Review 7.  Prevalence of gastroesophageal reflux in cystic fibrosis and implications for lung disease.

Authors:  Newell Bryce Robinson; Emily DiMango
Journal:  Ann Am Thorac Soc       Date:  2014-07

8.  J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.

Authors:  Edward Cantu; James Z Appel; Matthew G Hartwig; Hiwot Woreta; Cindy Green; Robert Messier; Scott M Palmer; R Duane Davis
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

9.  Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis.

Authors:  Bernardino M Mendez; Christopher S Davis; Cynthia Weber; Raymond J Joehl; P Marco Fisichella
Journal:  Am J Surg       Date:  2012-08-24       Impact factor: 2.565

10.  Correlation between the different pH-metry scores in gastroesophageal reflux disease in children.

Authors:  Vasile Valeriu Lupu; Ancuţa Ignat; Gabriela Paduraru; Anamaria Ciubara; Mihaela Moscalu; Cristina Oana Marginean; Marin Burlea
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more
  4 in total

1.  Cystic fibrosis and the gut.

Authors:  Mordechai Slae; Michael Wilschanski
Journal:  Frontline Gastroenterol       Date:  2020-10-27

2.  Epidemiology of Eosinophilic Esophagitis in Patients with Cystic Fibrosis: A Population-Based 5-Year Study.

Authors:  Omar Alaber; Ramy Sabe; Virginia Baez-Socorro; Senthilkumar Sankararaman; Erica Roesch; Thomas J Sferra
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2022-07-06

Review 3.  Focus on gastroesophageal reflux disease in patients with cystic fibrosis.

Authors:  Annarita Bongiovanni; Sara Manti; Giuseppe Fabio Parisi; Maria Papale; Enza Mulè; Novella Rotolo; Salvatore Leonardi
Journal:  World J Gastroenterol       Date:  2020-11-07       Impact factor: 5.742

Review 4.  Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.

Authors:  David F Woods; Stephanie Flynn; Jose A Caparrós-Martín; Stephen M Stick; F Jerry Reen; Fergal O'Gara
Journal:  Antibiotics (Basel)       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.